North America - United States • M&A/corporate and commercial
Fenwick & West LLP
We only have limited information for this firm. Consider the following firms which have provided more information:
The Fenwick & West LLP practice is valued by its client base of blue-chip corporations active particularly in the life sciences and tech sectors for its ‘measured and practical approach’ to public and private M&A. The team is also very experienced at handling growth investments and regularly represents venture capital clients and portfolio/target companies in cross-border acquisitions and series investments. Bomi Lee co-heads the team from San Francisco and specialises in divestitures and carve-out transactions, while New York-based co-head Ken Myers is an expert on joint ventures and tender offers. San Francisco lawyer Douglas Cogen focuses on shareholder activism and takeover defense issues, while Santa Monica-based Kris Withrow primarily advises on transactions in the TMT sector. In New York, Ethan Skerry concentrates on private equity-backed transactions and governance matters in the life sciences and software spaces, and in Silicon Valley, David Michaels is a key contact for debt finance matters, while Stephen Fisher is highly recommended for advising on exchange offers.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The Fenwick M&A team has deep technology experience and understand my company and industry well. As a result, they are not just lawyers for a deal, but true advisors to our management team. They take a measured and practical approach, and always achieve a fantastic result to my company.’
'The Fenwick M&A team is truly exceptional from a client service and quality of service perspective. The team, across partners, counsel and associates, is highly client focused and a great partner for us. Their level of attentiveness, communication and coordination across not only one but multiple matters make them an indispensable part of our team.'
Abbreviated data is displayed for this firm.
Key clients
- BILL Holdings
- Chinook Therapeutics
Abbreviated data is displayed for this firm.
Work highlights
- Advised Figma, a leading web-first collaborative design platform, on its pending $20bn acquisition by Adobe.
- Advised Chinook Therapeutics, Inc. on its $3.5bn acquisition by Novartis AG.
Abbreviated data is displayed for this firm.